Her2/neu overexpression in differentiated thyroid carcinomas predicts metastatic disease

Virchows Archiv

Volumn 442, Issue 4, 2003, Pages 322-328

  Kremser, R ^a   Obrist, P ^a   Spizzo, G ^a   Erler, H ^a   Kendler, D ^a   Kemmler, G ^a   Mikuz, G ^a   Ensinger, C ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Her2neu; Metastasis; Prognosis; Thyroid cancer

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; FORMALDEHYDE; MONOCLONAL ANTIBODY; ONCOPROTEIN; PROTEIN; RADIOACTIVE IODINE; TRASTUZUMAB; UNCLASSIFIED DRUG;

ADULT; AGED; AGGRESSION; ARTICLE; CLINICAL STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; DISEASE COURSE; FEMALE; FOLLICULAR CARCINOMA; FOLLOW UP; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS; PAPILLARY CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; RANK SUM TEST; RETROSPECTIVE STUDY; THYROID CARCINOMA; THYROID SURGERY; TISSUE FIXATION; TREATMENT OUTCOME;

EID: 0038702459     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-003-0769-3     Document Type: Article

References (38)

1. Akslen LA, Varhaug JE (1995) Oncoproteins and tumor progression in papillary thyroid carcinoma: presence of epidermal growth factor receptor, c-erbB-2 protein, estrogen receptor related protein, p21-ras protein, and proliferation indicators in relation to tumor recurrences and patient survival. Cancer 76:1643-1654
2. Akslen LA, Myking AO, Salvesen H, Varhaug JE (1993) Prognostic impact of EGF-receptor in papillary thyroid carcinoma. Br J Cancer 68:808-812
3. Allgayer H, Babic R, Gruetzner KU, Tarabichi A, Schildberg FW, Heiss MM (2000) C-erbB-2 is of independent prognostic relevance in gastric cancer and is associated with the expression of tumor-associated protease systems. J Clin Oncol 18:2201-2209
4. Berchuck A, Kamel A, Whitaker R, Kerns B, Olt G, Kinney R, Soper JT, Dodge R, Clarke-Pearson DL, Marks P (1990) Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer. Cancer Res 50:4087-4091
5. Carcangiu ML, Zampi G, Pupi A, Castagnoli A, Rosai J (1985) Papillary carcinoma of the thyroid. A clinicopathologic study of 241 cases treated at the University of Florence, Italy. Cancer 55:805-828
6. Chazin VR, Kaleko M, Miller AD, Slamon DJ (1992) Transformation mediated by the human HER-2 gene independent of the epidermal growth factor receptor. Oncogene 7:1859-1866
7. Coombs LM, Pigott DA, Sweeney E, Proctor AJ, Eydmann ME, Parkinson C, Knowles MA (1991) Amplification and overexpression of c-erbB-2 in transitional cell carcinoma of the urinary bladder. Br J Cancer 63:601-608
8. Cooper GM (ed) (1997) The cell, a molecular approach. ASM Press, Washington DC
9. Daneker G, Mercurio A, Guerra L, Wolf B, Salem R, Bagli D, Steele G (1987) Laminin expression in colorectal carcinomas varying in degree of differentiation. Arch Surg 122:1470-1474
10. Gullick WJ, Love SB, Wright C, Barnes DM, Gusterson B, Harris AL, Altman DG (1991) C-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes. Br J Cancer 63:434-438
11. Haugen DR, Akslen LA, Varhaug JE, Lillehaug JR (1992) Expression of c-erbB-2 protein in papillary thyroid carcinomas. Br J Cancer 65:832-837
12. Hedinger C, Williams ED, Sobin LH (1989) The WHO histological classification of thyroid tumors: a commentary on the second edition. Cancer 63:908-911
13. Hou L, Shi D, Tu SM, Zhang HZ, Hung MC, Ling D (1992) Oral cancer progression and c-erbB-2/neu proto-oncogene expression. Cancer Lett 65:215-220
14. Hung MC, Lau YK (1999) Basic science of HER-2/neu: a review. Semin Oncol 26:51-59
15. Hynes NE, Stern DF (1994) The biology of erbB-2/neu/HER-2 and its role in cancer. Biochim Biophys Acta 1198:165-184
16. Kornilova T, Taverna D, Hoeck W, Hynes NE (1992) Surface expression of erb B2 protein is post-transcriptionally regulated in mammary epithelial cells by epidermal growth factor and by the culture density. Oncogene 7:511-519
17. Kruger S, Weitsch G, Buttner H, Matthiensen A, Bohmer T, Marques F, Feller AC, Bohle A (2002) Her2 overexpression in muscle-invasive urothelial carcinomas of bladder. Int J Cancer 102:514-518
18. Lemoine NR, Wyllie FS, Lillehaug JR, Staddon SL, Hughes CM, Aasland R, Shaw J, Varhaug JE, Brown CL, Gullick WJ (1990) Absence of abnormalities of the c-erbB-1 and c-erbB-2 proto-oncogenes in human thyroid neoplasia. Eur J Cancer 26:777-779
19. Lovekin C, Ellis IO, Locker A, Robertson JF, Bell J, Nicholson R, Gullick WJ, Elston CW, Blamey RW (1991) C-erbB-2 oncoprotein expression in primary and advanced breast cancer. Br J Cancer 63:439-443 (erratum 64:202)
20. de Potter CR, Van Daele S, Van de Vijver MJ, Pauwels C, Maertens G, De Boever J, Vandekerckhove D, Roels H (1989) The expression of the neu oncogene product in breast lesions and in normal fetal and adult human tissues. Histopathology 15:351-362
21. Revillion F, Bonneterre J, Peyrat JP (1998) ERBB2 oncogene in human breast cancer and its clinical significance. Eur J Cancer 34:791-808
22. Rosai J, Carcangiu ML, DeLellis RA (1992) Tumors of the thyroid gland. In: Rosai J (ed) Atlas of tumor pathology, third series, fascicle 5. Armed Forces Institute of Pathology, Washington D.C., pp 96-116
23. Schneider J, Pollan M, Ruibal A, Jimenez E, Lucas AR, Nunez NI, Tejerina A (1999) Histologic high grade and CD44 are independent predictors of a node invasion in early (T1) breast cancer. Tumour Biol 20:319-330
24. Schneider PM, Hung MC, Chiocca SM, Manning J, Zhao XY, Fang K, Roth JA (1989) Differential expression of the c-erbB-2 gene in human small cell and non-small cell lung cancer. Cancer Res 49:4968-4971
25. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235:177-182
26. Soares P, Sambade C, Sobrinho-Simoes M (1994) Expression of C-erb B2 in tumours and tumour-like lesions of the thyroid. Int J Cancer 56:459-461
27. Stern DF, Heffernan PA, Weinberg RA (1986) P185, a product of the neu proto-oncogene, is a receptorlike protein associated with tyrosine kinase activity. Mol Cell Biol 6:1729-1740
28. Tan M, Yao J, Yu D (1997) Overexpression of the c-erb-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities. Cancer Res 57:1199-1205
29. Utrilla JC, Martin-Lacave I, San Martin MV, Fernandez-Santos JM, Galera-Davidson H (1999) Expression of c-erbB-2 oncoprotein in human thyroid tumours. Histopathology 34:60-65
30. Weiner DB, Nordberg J, Robinson R, Nowell PC, Gazdar A, Greene MI, Williams WV, Cohen JA, Kern JA (1990) Expression of the neu gene-encoded protein (P185neu) in human non-small cell carcinomas of the lung. Cancer Res 50:421-425
31. Westermark B, Magnusson A, Heldin CH (1982) Effect of epidermal growth factor on membrane motility and cell locomotion in cultures of human clonal glioma cells. J Neurosci Res 8:491-507
32. Wiechen K, Karaaslan S, Dietel M (1999) Involvement of the c-erbB-2 oncogene product in the EGF-induced cell motility of SK-OV-3 ovarian cancer cells. Int J Cancer 83:409-414
33. Xia W, Lau YK, Zhang HZ, Liu AR, Li L, Kiyokawa N, Clayman GL, Katz RL, Hung MC (1997) Strong correlation between c-erbB-2 overexpression and overall survival of patients with oral squamous cell carcinoma. Clin Cancer Res 3:3-9
34. Yokota J, Yamamoto T, Miyajima N, Toyoshima K, Nomura N, Sakamoto H, Yoshida T, Terada M, Sugimura T (1988) Genetic alterations of the c-erbB-2 oncogene occur frequently in tubular adenocarcinoma of the stomach and are often accompanied by amplification of the v-erbA homologue. Oncogene 2:283-287
35. Yoshida K, Tsuda T, Matsumura T, Tsujino T, Hattori T, Ito H, Tahara E (1989) Amplification of epidermal growth factor receptor (EGFR) gene and oncogenes in human gastric carcinomas. Virchows Arch 57:285-290
36. Yu D, Wang SS, Dulski KM, Tsai CM, Nicolson GL, Hung MC (1994) C-erbB-2/neu overexpression enhances metastatic potential of human lung cancer cells by induction of metastasis-associated properties. Cancer Res 54:3260-3266
37. Yu DH, Hung MC (1991) Expression of activated rat neu oncogene is sufficient to induce experimental metastasis in 3T3 cells. Oncogene 6:1991-1996
38. Zhang X, Silva E, Gershenson D, Hung MC (1989) Amplification and rearrangement of c-erb B proto-oncogenes in cancer of human female genital tract. Oncogene 4:985-989